IR
63
-3
HAS
30
-2
AMAT
33
-13
JWN
48
-2
DG
8
-2
CCI
30
-11
ADBE
47
-9
LEN
50
-2
STX
45
-4
CMI
64
-3
KMX
61
-3
WBA
43
-4
GRMN
67
-4
PYPL
52
-2
CTSH
60
-3
WYNN
36
-5
CA
22
-3
LUV
45
-2
CFG
74
2
TXN
43
-5
IR
63
-3
HAS
30
-2
AMAT
33
-13
JWN
48
-2
DG
8
-2
CCI
30
-11
ADBE
47
-9
LEN
50
-2
STX
45
-4
CMI
64
-3
KMX
61
-3
WBA
43
-4
GRMN
67
-4
PYPL
52
-2
CTSH
60
-3
WYNN
36
-5
CA
22
-3
LUV
45
-2
CFG
74
2
TXN
43
-5
Financhill
Back

SPDR® SSgA Multi-Asset Real Return ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
27

RLY
SPDR® SSgA Multi-Asset Real Return ETF

Last Price:
28.45
Seasonality Move:
0.11%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
27
SPDR® SSgA Multi-Asset Real Return ETF (RLY) is a Sell

Is SPDR® SSgA Multi-Asset Real Return ETF a Buy, Sell or Hold?

  • The current SPDR® SSgA Multi-Asset Real Return ETF [RLY] share price is $28.15. The Score for RLY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • RLY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLY Stock Price Chart

What is SPDR® SSgA Multi-Asset Real Return ETF's stock price today?

  • The SPDR® SSgA Multi-Asset Real Return ETF share price today is $28.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLY is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 40.88 Sell
Chaikin Money Flow: 16342 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.3 - 28.82) Sell
Bollinger Bands (100): (27.67 - 28.69) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.41 Sell
20-day SMA: 28.48 Sell
50-day SMA: 28.52 Sell
200-day SMA: 27.93 Buy
8-day EMA: 28.3 Sell
20-day EMA: 28.45 Sell
50-day EMA: 28.44 Sell
200-day EMA: 28.01 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

SPDR® SSgA Multi-Asset Real Return ETF Earnings Growth & RLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

SPDR® SSgA Multi-Asset Real Return ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):